Literature DB >> 8930061

Autism and epilepsy (and tuberous sclerosis?) in two pre-adolescent boys: neuropsychiatric aspects before and after epilepsy surgery.

C Gillberg1, P Uvebrant, G Carlsson, A Hedstrom, H Silfvenius.   

Abstract

We report on two pre-adolescent boys with a combination of severe seizure disorders and severe-moderate autism who underwent brain surgery for their epilepsy at the ages of 9 and 10 years, respectively. Both boys became seizure-free and initially improved dramatically with regard to autism symptoms. One of the boys continued to improve, but the other had a relapse to his pre-operative state in conjunction with his pubertal growth spurt. Several years after surgery, one of the boys remained much improved with respect to his autism. The other subject showed some improvement with respect to self-injury and aggression, and had slightly lower scores on screens for autism symptoms than in the year preceding epilepsy surgery. The histopathological examination of the brain tissue that was removed at surgery suggested a diagnosis of tuberous sclerosis in both cases.

Entities:  

Mesh:

Year:  1996        PMID: 8930061     DOI: 10.1111/j.1365-2788.1996.tb00606.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  2 in total

Review 1.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

2.  Everolimus and intensive behavioral therapy in an adolescent with tuberous sclerosis complex and severe behavior.

Authors:  Tanjala T Gipson; Heather Jennett; Lee Wachtel; Mary Gregory; Andrea Poretti; Michael V Johnston
Journal:  Epilepsy Behav Case Rep       Date:  2013-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.